SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VOLINIA, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.182
AS - Asia 12.604
EU - Europa 6.306
SA - Sud America 2.052
Continente sconosciuto - Info sul continente non disponibili 418
AF - Africa 289
OC - Oceania 18
Totale 49.869
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.602
SG - Singapore 4.700
CN - Cina 3.010
BR - Brasile 1.572
VN - Vietnam 1.482
IT - Italia 1.138
UA - Ucraina 1.125
DE - Germania 1.099
HK - Hong Kong 1.074
TR - Turchia 852
GB - Regno Unito 652
FI - Finlandia 450
BD - Bangladesh 388
PL - Polonia 358
FR - Francia 356
SE - Svezia 356
RU - Federazione Russa 341
IN - India 242
CA - Canada 235
MX - Messico 211
JP - Giappone 208
AR - Argentina 162
ID - Indonesia 161
ZA - Sudafrica 92
ES - Italia 84
NL - Olanda 82
IQ - Iraq 78
CO - Colombia 72
EC - Ecuador 71
AT - Austria 56
PK - Pakistan 54
BE - Belgio 48
VE - Venezuela 48
UZ - Uzbekistan 47
CL - Cile 41
SA - Arabia Saudita 41
MA - Marocco 39
LT - Lituania 35
TN - Tunisia 33
JM - Giamaica 31
PY - Paraguay 31
PH - Filippine 28
KE - Kenya 27
IR - Iran 25
MY - Malesia 23
CR - Costa Rica 22
EG - Egitto 22
UY - Uruguay 22
CZ - Repubblica Ceca 20
ET - Etiopia 18
JO - Giordania 18
AE - Emirati Arabi Uniti 16
AU - Australia 16
PS - Palestinian Territory 16
IL - Israele 15
PE - Perù 15
AZ - Azerbaigian 14
HN - Honduras 14
NP - Nepal 14
RO - Romania 14
DZ - Algeria 13
KR - Corea 13
AL - Albania 11
BO - Bolivia 11
CH - Svizzera 10
KZ - Kazakistan 10
OM - Oman 10
SV - El Salvador 10
TH - Thailandia 10
GR - Grecia 9
GT - Guatemala 9
NI - Nicaragua 9
NG - Nigeria 8
TW - Taiwan 8
HU - Ungheria 7
LB - Libano 7
TT - Trinidad e Tobago 7
BB - Barbados 6
BG - Bulgaria 6
BH - Bahrain 6
DO - Repubblica Dominicana 6
PA - Panama 6
RS - Serbia 6
DK - Danimarca 5
GA - Gabon 5
MD - Moldavia 5
PT - Portogallo 5
SN - Senegal 5
SY - Repubblica araba siriana 5
BA - Bosnia-Erzegovina 4
CI - Costa d'Avorio 4
GD - Grenada 4
GE - Georgia 4
IE - Irlanda 4
KW - Kuwait 4
LV - Lettonia 4
LY - Libia 4
SK - Slovacchia (Repubblica Slovacca) 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
Totale 49.387
Salva come PNG Salva come JPEG
Città #
Fairfield 3.010
Singapore 2.934
Ashburn 2.742
Woodbridge 2.710
San Jose 1.663
Houston 1.612
Seattle 1.260
Jacksonville 1.246
Ann Arbor 1.190
Chandler 1.097
Hong Kong 1.052
Cambridge 997
Wilmington 997
Santa Clara 915
Beijing 893
Council Bluffs 635
Ho Chi Minh City 464
Dallas 458
Izmir 450
Los Angeles 376
Nanjing 359
Warsaw 341
Hanoi 333
New York 312
Princeton 287
Addison 248
San Diego 248
Lauterbourg 239
Ferrara 235
Boardman 202
Munich 202
Tokyo 196
Milan 195
São Paulo 151
Helsinki 140
Shanghai 127
Nanchang 119
Buffalo 117
Mexico City 114
Orem 107
Jakarta 102
London 95
Shenyang 93
Dearborn 91
Hebei 84
The Dalles 84
Tianjin 84
Hefei 80
Toronto 80
Atlanta 71
Bremen 71
Chicago 71
Turku 70
Da Nang 68
Denver 68
Falls Church 65
Brooklyn 62
Rome 62
Haiphong 61
Mountain View 59
Jiaxing 57
San Mateo 57
Frankfurt am Main 56
Johannesburg 56
Stockholm 55
Jinan 52
Phoenix 52
Changsha 50
Rio de Janeiro 50
Montreal 49
Redwood City 47
Falkenstein 45
Brussels 44
Boston 43
Chennai 43
Columbus 42
Amsterdam 41
Moscow 41
Nuremberg 40
Tashkent 40
Guangzhou 39
Kunming 39
San Francisco 39
Mumbai 38
Belo Horizonte 37
Bologna 36
Manchester 35
Baghdad 33
Poplar 33
Norwalk 31
Dong Ket 30
Ankara 29
Brasília 29
Ningbo 29
Philadelphia 29
Des Moines 28
Vienna 28
Hangzhou 27
Orange 27
Porto Alegre 27
Totale 34.097
Salva come PNG Salva come JPEG
Nome #
Loss of miR-204 expression is a key event in melanoma 292
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. 281
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors 277
miRNA signatures associate with pathogenesis and progression of osteosarcoma. 266
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis 264
A miRNA signature for defining aggressive phenotype and prognosis in gliomas 262
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells 261
Correlation of expression between different IMAGE clones from the same UniGene cluster 259
MicroRNA expression profiling in human Barrett's carcinogenesis. 258
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 256
MicroRNA Expression Signatures in Solid Malignancies 255
A microRNA signature for a BMP2-induced osteoblast lineage commitment program 245
Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset 243
Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples 242
Association between idiopathic hearing loss and mitochondrial DNA mutations: a study on 169 hearing-impaired subjects 241
Identification of microRNA activity by Targets' Reverse EXpression. 240
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 236
Prion proteins (PRNP and PRND) are over-expressed in osteosarcoma 234
Reprogramming of miRNA networks in cancer and leukemia 230
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 230
Microevolution in Ferrara: Isonymy 1890–1990 230
Analysis of osteoblast-like MG63 cells' response to a rough implant surface by means of DNA microarray 229
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia 228
Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites 227
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation 226
A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K+ Channel in Breast Cancer 225
The downregulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. 225
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma 223
GAMES identifies and annotates mutations in next-generation sequencing projects 223
p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. 222
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma 221
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia 221
A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia 219
B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice 219
Circulating tumor cells share RNA modules with early embryo trophectoderm and with metastatic cancer 219
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells 218
RNA analysis indicates tight correlation between the expression of a long non coding RNA and the TG2 mRNA levels 215
Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer 214
Analysis of Differential Expression of TG2 Variants During Treatment with Retinoic Acid Highlights a New 3'-Terminal Transcript and Putatively Involved Proteins 214
Onconase mediated NFKβ downregulation in malignant pleural mesothelioma 213
A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants 212
miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. 211
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis 211
Druggable Molecular Networks in BRCA1/BRCA2-Mutated Breast Cancer 211
Espressione dei MicroRNA nei carcinomi mammari 207
Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts 207
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B 204
Strong inverse correlation between MicroRNA-125b and human papillomavirus DNA in productive infection 204
A RECURRENT AMINOACID SUBSTITUTION AND A PARTIAL GENE DELETION IN SEVERE HEMOPHILIA A 201
The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model 201
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 201
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 200
TOM: Transcriptomics of OMIM. 200
CG Dinucleotides of class II MHC genes are mutation hot-spots 200
Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. 200
Involvement of non-coding RNAs and transcription factors in the induction of Transglutaminase isoforms by ATRA 200
Profiling of the Predicted Circular RNAs in Ductal In Situ and Invasive Breast Cancer: A Pilot Study 200
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas 199
Inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations 199
WWOX and p53 dysregulation synergize to drive the development of osteosarcoma 197
Partial gene deletion in a family with factor X deficiency 196
CHARACTERIZATION OF THE PSEUDOGENIC REGION OF VON WILLEBRAND FACTOR BY MOLECULAR CLONING AND "IN SITU" HYBRIDIZATION 195
SNPs and somatic mutation on long non-coding RNA: New frontier in the cancer studies? 195
GAS6 expression identifies high-risk adult AML patients: potential implications for therapy. 194
SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome 193
Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia 193
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML 192
Comparison of microRNA deep sequencing of matched formalin-fixed paraffin-embedded and fresh frozen cancer tissues. 190
Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer 189
Expression profiles of craniosynostosis-derived fibroblasts 188
The role of microRNA genes in papillary thyroid carcinoma 188
The miR-1792 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes 187
Suppression of MicroRNA-9 by Mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity 187
ATRA modulates the expression of alternative Transglutaminase 2 in brain tumors through interactions between regulatory factors and intronic regions 186
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis 186
Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway 185
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer 184
Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer 183
Modulation of mismatch repair and genomic stability by miR-155 181
GOAL: automated gene ontology analisys of expression profiles. 179
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 178
MicroRNA profiles discriminate among colon cancer metastasis 178
Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer 177
The network of non-coding RNAs in cancer drug resistance 177
Inhibition of the lncRNA Coded within Transglutaminase 2 Gene Impacts Several Relevant Networks in MCF-7 Breast Cancer Cells 177
UC.183, UC.110, and UC.84 ultra-conserved RNAs are mutually exclusive with mir-221 and are engaged in the cell cycle circuitry in breast cancer cell lines 177
A microRNA expression signature of human solid tumors defines cancer gene targets 175
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia 174
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 174
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells 173
miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology 171
Circular RNAs Could Encode Unique Proteins and Affect Cancer Pathways 170
The network of non-coding RNAs and their molecular targets in breast cancer 170
Functional Implications of MicroRNAs in Acute Myeloid Leukemia by Integrating MicroRNA and Messenger RNA Expression Profiling 169
MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis 169
The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism 169
A HIND III RFLP AND A GENE LESION IN THE COAGULATION FACTOR-VIII GENE 168
Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression 168
GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGFβ effectors, Drosha and microRNAs with opposite oncogenic potentials 167
Mutational landscape and gene-expression patterns in adult acute myeloid leukemias with monosomy 7 as a sole abnormality 167
Totale 20.787
Salva come PNG Salva come JPEG
Categoria #
all - tutte 211.114
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.459
Totale 213.573
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.660 0 0 351 56 137 117 155 116 93 243 293 1.099
2022/20232.647 275 114 90 300 443 409 115 247 367 26 166 95
2023/20241.240 155 203 61 38 74 177 63 61 31 25 51 301
2024/20255.665 155 154 476 211 697 441 186 393 931 626 768 627
2025/202616.943 1.506 749 1.585 2.156 2.337 990 1.991 990 1.669 1.740 825 405
2026/20271.839 451 955 433 0 0 0 0 0 0 0 0 0
Totale 49.869